food and drug administration (fda)

  1. FDA gives go-ahead for MN166 (ibudilast) to begin phase 2b/3 clinical trials

    Approval for next phase of clinical trials puts ALS patients one step closer to accessing new treatment shown to slow disease progression.

    FDA Ibudilast molecule and pills

    Read more »
  2. Edaravone availability in the US - one month to go

    As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.edaravone best price

    Read more »
  3. PrEP for HIV Prevention

    With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

    PrEP for HIV Prevention

    Read more »
  4. 5 things you need to know about multiple sclerosis (MS)

    Get the latest news on MS research, the FDA approval of Ocrevus (ocrelizumab) for both relapsing and progressive forms of MS, insights and resources.

    multiple sclerosis

    Read more »
  5. Accessing edaravone in your country - the new FDA approved drug for ALS

    What are the results from the clinical studies that led to the approval of edaravone, and how can patients access it in their country?

    edaravone FDA ALS

    Read more »
  6. The pricing controversy surrounding Duchenne muscular dystrophy (DMD) treatment

    The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment

     Duchenne muscular dystrophy (DMD) treatment price

    Read more »
  7. Daratumumab approved as multiple myeloma treatment

    The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. 

    Daratumumab multiple myeloma treatment

    Read more »